Discontinued St. Jude catheter finds new life at Vascular Solutions

Vascular Solutions is paying $3 million to acquire St. Jude Medical's Venture catheter product line, which MedCity News reports as discontinued in July 2011. CEO Phil Nalbone admitted to the news organization that the product isn't used very much. That, in part, is because it is used to help provide control for complex coronary and vascular procedures, among other issues. But Venture remains in demand because it has no competition. As a result, it has offered real benefit and doctors continue to find it useful, Nalbone is quoted as saying. Story

Like what you're reading?
Click here to get more news like this delivered to your inbox>>

Suggested Articles

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.